Table of Contents

company-logo

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.

Nymox Pharmaceutical Dividend Announcement

• Nymox Pharmaceutical does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Nymox Pharmaceutical dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Nymox Pharmaceutical Dividend History

Nymox Pharmaceutical Dividend Yield

Nymox Pharmaceutical current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Nymox Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:

Nymox Pharmaceutical Financial Ratios

P/E ratio-2.61
PEG ratio-0.03
P/B ratio-6.34
ROE406.09%
Payout ratio0.00%
Current ratio0.07
Quick ratio0.05
Cash Ratio0.04

Nymox Pharmaceutical Dividend FAQ

Does Nymox Pharmaceutical stock pay dividends?
Nymox Pharmaceutical does not currently pay dividends to its shareholders.
Has Nymox Pharmaceutical ever paid a dividend?
No, Nymox Pharmaceutical has no a history of paying dividends to its shareholders. Nymox Pharmaceutical is not known for its dividend payments.
Why doesn't Nymox Pharmaceutical pay dividends?
There are several potential reasons why Nymox Pharmaceutical would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Nymox Pharmaceutical ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Nymox Pharmaceutical has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Nymox Pharmaceutical a dividend aristocrat?
Nymox Pharmaceutical is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Nymox Pharmaceutical a dividend king?
Nymox Pharmaceutical is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Nymox Pharmaceutical a dividend stock?
No, Nymox Pharmaceutical is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Nymox Pharmaceutical stocks?
To buy Nymox Pharmaceutical you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Nymox Pharmaceutical stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.